Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Reprod Sci ; 31(5): 1278-1289, 2024 May.
Article in English | MEDLINE | ID: mdl-38228974

ABSTRACT

Concerns have been raised about potentially irreversible brain damage and damage to the neuroendocrine system during development when treating attention-deficit/hyperactivity disorder with lisdexamfetamine (LDX), a norepinephrine dopamine reuptake inhibitor. This study aims to elucidate the potential adverse effects of LDX on the male reproductive system due to its widespread use and potential for abuse. In this study, adult male rats were randomized into control and LDX groups. Thirty milligrams per kilogram LDX was administered orally for 3 weeks. After isolation of epididymal spermatozoa, the rats were euthanized and testicular tissues were collected for stereological and molecular analyses. The LDX group showed a decrease in sperm motility and an increase in DNA fragmentation compared to the control group. There was also a dramatic decrease in testosterone in the LDX group. Testicular expression of caspase-3 and TNF-α was significantly increased in the LDX group. According to our findings, prolonged use of LDX leads to reduced sperm quality. It also induces apoptosis, inflammatory response, and pathological changes in the testicular tissue. What we have observed in this study is noteworthy but requires further investigation, particularly in people who use LDX over a longer period of time.


Subject(s)
Apoptosis , Lisdexamfetamine Dimesylate , Sperm Motility , Spermatozoa , Testis , Animals , Male , Apoptosis/drug effects , Spermatozoa/drug effects , Spermatozoa/pathology , Lisdexamfetamine Dimesylate/toxicity , Testis/drug effects , Testis/pathology , Testis/metabolism , Sperm Motility/drug effects , Rats, Sprague-Dawley , Inflammation/chemically induced , Inflammation/pathology , Rats , Testosterone , DNA Fragmentation/drug effects , Caspase 3/metabolism
2.
Metab Brain Dis ; 38(8): 2735-2750, 2023 12.
Article in English | MEDLINE | ID: mdl-37851137

ABSTRACT

Epilepsy significantly reduces the patient's quality of life, and we still need to develop new therapeutic approaches to control it. Transplantation of cells such as Sertoli cells (SCs), having a potent ability to release a variety of growth and immunoprotective substances, have made them a potential candidate to deal with neurological diseases like epilepsy. Hence, this study aims to evaluate whether SCs transplant effectively protects the hippocampus astrocytes and neurons to oppose seizure damage. For this purpose, the effects of bilateral intrahippocampal transplantation of SCs were investigated on the rats with the pentylenetetrazol (PTZ) induced seizure. After one-month, post-graft analysis was performed regarding behavior, immunohistopathology, and the distribution of the hippocampal cells. Our findings showed SCs transplantation reduced astrogliosis, astrocytes process length, the number of branches, and intersections distal to the soma of the hippocampus in the seizure group. In rats with grafted SCs, there was a drop in the hippocampal caspase-3 expression. Moreover, the SCs showed another protective impact, as shown by an improvement in pyramidal neurons' number and spatial distribution. The findings suggested that SCs transplantation can potently modify astrocytes' reactivation and inflammatory responses.


Subject(s)
Epilepsy , Sertoli Cells , Male , Rats , Humans , Animals , Sertoli Cells/pathology , Quality of Life , Seizures/drug therapy , Epilepsy/drug therapy , Hippocampus/metabolism , Cell Death , Amnesia/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...